Suppr超能文献

囊内神经鞘瘤切除术的长期随访

Long-term Follow-up of Intracapsular Schwannoma Excision.

作者信息

Niepel Albert Laurenz, Steinkellner Lara, Sokullu Fuat, Hellekes Dirk, Kömürcü Fercan

机构信息

Medical University of Vienna, Vienna, Austria.

出版信息

Ann Plast Surg. 2019 Mar;82(3):296-298. doi: 10.1097/SAP.0000000000001812.

Abstract

INTRODUCTION

The current criterion-standard treatment for schwannomas is intracapsular excision. This study was designed as a long-term follow-up to investigate postoperative symptoms, nervous impairment, and recurrence rate.

METHODS

We performed a long-term follow-up of 18 subjects who underwent intracapsular schwannoma excision. We evaluated preoperative versus postoperative 2-point discrimination (2-PD) in the affected dermatome, pain (visual analog scale [VAS] from 0-10), Hoffmann-Tinel sign, and thermoreceptor response. For reasons of comparison, all examinations were done on both the healthy and affected extremity.

RESULTS

Last postoperative follow-up was done on average after approximately 50.4 months. Comparison between preoperative and postoperative sensibility testing (2-PD) in the affected dermatome showed a significant improvement of 22.7% after surgery (5-mm 2-PD; P = 0.02). Compared with the healthy nonoperated extremity preoperatively, subjects showed a significant sensory deficit of 40.9% (9-mm 2-PD; P < 0.000). Postoperatively, 12 of 18 subjects still showed a deficit in 2-PD. However, deficiency was decreased to 23.5% (mean, 4-mm 2-PD; P = 0.003). Through intracapsular schwannoma excision, subjects could drastically improve their pain (from VAS 6.7 to VAS 4.0).During our examination, we clinically suspected recurrence in 3 subjects, which were sent to magnetic resonance imaging to rule out or confirm a recurrent tumor.

DISCUSSION

Many subjects reported ongoing pain and sensory deficits after intracapsular excision of schwannomas. Symptoms right after surgery may be due to iatrogenic nerve injury or residual deficits from compression damage of the tumor mass. As schwannomas are usually growing at a slow rate, early symptoms after a symptom-free period might possibly indicate scarring of soft tissue, which may cause signs of recurrent neurological deficits or pain. Patients with a late onset of symptoms are at the highest risk of having a true recurrence of schwannoma. None of the 3 suspected subjects showed radiological evidence for a recurrent schwannoma, but rather scarring and soft tissue adhesions to the nerve, which could explain the clinical findings.Intracapsular removal of schwannomas is relatively easy to perform, does not cause any additional damage to the nerve in most cases, and is therefore an excellent method for treatment of symptomatic schwannoma patients.

摘要

引言

目前神经鞘瘤的标准治疗方法是囊内切除术。本研究旨在进行长期随访,以调查术后症状、神经损伤和复发率。

方法

我们对18例行神经鞘瘤囊内切除术的患者进行了长期随访。我们评估了患侧皮节术前与术后的两点辨别觉(2-PD)、疼痛(视觉模拟评分法[VAS],范围为0-10)、霍夫曼征和温度觉反应。为了进行比较,所有检查均在健侧和患侧肢体上进行。

结果

术后平均约50.4个月进行了最后一次随访。患侧皮节术前与术后感觉测试(2-PD)的比较显示,术后有显著改善,改善率为22.7%(2-PD为5mm;P=0.02)。与术前健侧未手术肢体相比,患者存在显著的感觉缺陷,缺陷率为40.9%(2-PD为9mm;P<0.000)。术后,18例患者中有12例仍存在2-PD缺陷。然而,缺陷率降至23.5%(平均2-PD为4mm;P=0.003)。通过神经鞘瘤囊内切除术,患者的疼痛可大幅改善(从VAS 6.7降至VAS 4.0)。在我们的检查中,我们临床怀疑3例患者复发,将其送去进行磁共振成像检查以排除或确认复发性肿瘤。

讨论

许多患者报告在神经鞘瘤囊内切除术后仍持续存在疼痛和感觉缺陷。术后立即出现的症状可能是由于医源性神经损伤或肿瘤肿块压迫损伤导致的残留缺陷。由于神经鞘瘤通常生长缓慢,无症状期后的早期症状可能表明软组织瘢痕形成,这可能导致复发性神经功能缺损或疼痛的体征。症状出现较晚的患者发生神经鞘瘤真正复发的风险最高。3例疑似患者均未显示神经鞘瘤复发的影像学证据,而是瘢痕形成以及神经与软组织粘连,这可以解释临床发现。神经鞘瘤囊内切除术操作相对容易,在大多数情况下不会对神经造成任何额外损伤,因此是治疗有症状神经鞘瘤患者的一种极佳方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验